Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SUBCITRATE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 198 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Islek, I; Uysal, S; Gok, F; Dundaroz, R; Kucukoduk, S
      Reversible nephrotoxicity after overdose of colloidal bismuth subcitrate

      PEDIATRIC NEPHROLOGY
    2. Leussink, BT; Slikkerveer, A; Engelbrecht, MRW; van der Voet, GB; Nouwen, EJ; de Heer, E; de Broe, ME; de Wolff, FA; Bruijn, JA
      Bismuth overdosing-induced reversible nephropathy in rats

      ARCHIVES OF TOXICOLOGY
    3. Leussink, BT; Litvinov, SV; de Heer, E; Slikkerveer, A; van der Voet, GB; Bruijn, JA; de Wolff, FA
      Loss of homotypic epithelial cell adhesion by selective N-cadherin displacement in bismuth nephrotoxicity

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    4. Briand, GG; Burford, N; Cameron, TS
      The first ester complexes of bismuth(III) using thiolate anchored bifunctional ligands

      CHEMICAL COMMUNICATIONS
    5. Asato, E; Kamamuta, K; Imade, R; Yamasaki, M
      Solution structures and ligand exchange dynamics of bismuth(III) complexeswith nitrilotriacetic acid and N-(2-hydroxyethyl)iminodiacetic acid

      INORGANIC REACTION MECHANISMS
    6. Andersen, LP; Colding, H; Kristiansen, JE
      Potentiation of the action of metronidazole on Helicobacter pylori by omeprazole and bismuth subcitrate

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    7. Nijevitch, AA; Farztdinov, KM; Sataev, VU; Khasanov, RS; Katayev, VA; Khusnutdinov, SM; Akhunov, ED; Kazykhanov, NS
      Helicobacter pylori infection in childhood: Results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

    8. Anti-ulcer agents: indications in adult patients. Recommendations for goodpractice

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    9. Leussink, BT; Slikkerveer, A; Krauwinkel, WJJ; van der Voet, GB; de Heer, E; de Wolff, FA; Bruijn, JA
      Bismuth biokinetics and kidney histopathology after bismuth overdose in rats

      ARCHIVES OF TOXICOLOGY
    10. Weusten, BLAM; Sicking, PJM; Otten, HW; Smout, AJPM; Otten, MH
      Relief of dyspeptic symptoms by colloidal bismuth subcitrate in Helicobacter-negative and -positive patients: results of a study in general practice

      NETHERLANDS JOURNAL OF MEDICINE
    11. Miwa, H; Hirai, S; Nagahara, A; Murai, T; Nishira, T; Kikuchi, S; Takei, Y; Watanabe, S; Sato, N
      Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients - a double-blind placebo-controlled study

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    12. Oderda, G; Rapa, A; Bona, G
      A systematic review of Helicobacter pylori eradication treatment schedulesin children

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    13. Dore, MP; Leandro, G; Realdi, G; Sepulveda, AR; Graham, DY
      Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy - A meta-analytical approach

      DIGESTIVE DISEASES AND SCIENCES
    14. Danesh, J; Lawrence, M; Murphy, M; Roberts, S; Collins, R
      Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia

      ARCHIVES OF INTERNAL MEDICINE

    15. Anti-ulcer agents: indications in adults

      ANNALES DE MEDECINE INTERNE
    16. Talley, NJ; Janssens, J; Lauritsen, K; Racz, I; Bolling-Sternevald, E
      Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up

      BRITISH MEDICAL JOURNAL
    17. Sousa, MC; Poiares-Da-Silva, J
      Cytotoxicity induced by bismuth subcitrate in Giardia lamblia trophozoites

      TOXICOLOGY IN VITRO
    18. Dhali, GK; Garg, PK; Sharma, MP
      Role of anti-Helicobacter pylori treatment in H-Pylori-positive and cytoprotective drugs in H-Pylori-negative, non-ulcer dyspepsia: Results of a randomized, double-blind, controlled trial in Asian Indians

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    19. Stratton, CW; Warner, RR; Coudron, PE; Lilly, NA
      Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori: ultrastructural evidence for a mechanism of action for bismuth salts

      Journal of antimicrobial chemotherapy
    20. Buring, SM; Winner, LH; Hatton, RC; Doering, PL
      Discontinuation rates of Helicobacter pylori treatment regimens: A meta-analysis

      PHARMACOTHERAPY
    21. Worku, ML; Sidebotham, RL; Karim, QN
      Effects of ranitidine bismuth citrate on Helicobacter pylori motility, morphology and survival

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    22. Catalano, F; Branciforte, G; Brogna, A; Bentivegna, C; Luca, S; Terranova, R; Michalos, A; Dawson, BK; Chodash, HB
      Helicobacter pylori-positive functional dyspepsia in elderly patients - Comparison of two treatments

      DIGESTIVE DISEASES AND SCIENCES
    23. Unge, P
      Antibiotic treatment of Helicobacter pylori infection

      GASTRODUODENAL DISEASE AND HELICOBACTER PYLORI
    24. Sandha, GS; Hunt, RH; van Zanten, SJOV
      A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    25. Vyas, SP; Sihorkar, V; Kanaujia, P; Jaitely, V; Venkatesan, N
      Therapeutic and clinical regimens against Helicobacter pylori infections in humans: an overview

      PHARMAZIE
    26. Xia, HHX; Talley, NJ
      Helicobacter pylori eradication in patients with non-ulcer dyspepsia

      DRUGS
    27. Aal, GMA; Dajani, AI; Nounou, M; Awad, S; Rasheed, ZA; Gautam, S; Ukabam, S; Nayal, S
      Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week

      DIGESTION
    28. Sadler, PJ; Li, HY; Sun, HZ
      Coordination chemistry of metals in medicine: target sites for bismuth

      COORDINATION CHEMISTRY REVIEWS
    29. Yamamoto, Y; Hakki, A; Friedman, H; Okubo, S; Shimamura, T; Hoffman, PS; Rossignol, JF
      Nitazoxanide, a nitrothiazolide antiparasitic drug, is an anti-Helicobacter pylori agent with anti-vacuolating toxin activity

      CHEMOTHERAPY
    30. Briand, GG; Burford, N
      Bismuth compounds and preparations with biological or medicinal relevance

      CHEMICAL REVIEWS
    31. Greenberg, PD; Cello, JP
      Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia

      ARCHIVES OF INTERNAL MEDICINE
    32. Mearin, F; Balboa, A; Zarate, N; Cucala, M; Malagelada, JR
      Placebo in functional dyspepsia: Symptomatic, gastrointestinal motor, and gastric sensorial responses

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    33. PARKINSON JA; SUN HZ; SADLER PJ
      NEW APPROACH TO THE SOLUTION CHEMISTRY OF BISMUTH CITRATE ANTIULCER COMPLEXES

      Chemical communications
    34. GISBERT JP; BOIXEDA D; DEARGILA CM; PLAZA AG
      HELICOBACTER-PYLORI AND NONULCER DYSPEPSI A - A MATTER PENDING

      Revista espanola de enfermedades digestivas
    35. Unge, P
      Antimicrobial treatment of H-pylori infection - a pooled efficacy analysisof eradication therapies

      EUROPEAN JOURNAL OF SURGERY
    36. BATTAGLIA G; DIMARIO F; LEANDRO G; BENVENUTI ME; DONISI PM; VIANELLO F; DALBO N; PASINI M; PASQUINO M; VIGNERI S
      OPTIMAL PPI-BASED TRIPLE THERAPY FOR THE CURE OF HELICOBACTER-PYLORI INFECTION - A SINGLE-CENTER COMPARISON OF 4 14-DAY SCHEDULES

      Helicobacter
    37. Pantoflickova, D; Blum, AL; Koelz, HR
      Helicobacter pylori and functional dyspepsia: a real causal link?

      BAILLIERES CLINICAL GASTROENTEROLOGY
    38. Unge, P
      Are there more clinically important complications of Helicobacter pylori infection than peptic ulcer disease? A review of current literature

      JOURNAL OF GASTROENTEROLOGY
    39. LU CL; CHANG FY; CHEN TS; CHEN CY; JIUN KL; LEE SD
      HELICOBACTER-PYLORI COLONIZATION DOES NOT INFLUENCE THE SYMPTOMATIC RESPONSE TO PROKINETIC AGENTS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA

      Journal of gastroenterology and hepatology
    40. WEWER V; ANDERSEN LP; PAERREGAARD A; GERNOW AB; HANSEN JPH; MATZEN P; KRASILNIKOFF PA
      THE PREVALENCE AND RELATED SYMPTOMATOLOGY OF HELICOBACTER-PYLORI IN CHILDREN WITH RECURRENT ABDOMINAL-PAIN

      Acta paediatrica
    41. Marazova, K; Klouchek, E; Popov, A; Ivanov, C; Krushkov, I; Ichikawa, T; Ishihara, K; Hotta, K
      Effect of roxatidine bismuth citrate (MX1) against acetylsalicylic acid- and indomethacin-induced gastric mucosal damage in rats

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    42. CARVALHO AF; FIORELLI LA; JORGE VNC; DASILVA CJF; DENUCCI G; FERRAZ JGP; PEDRAZZOLI J
      ADDITION OF BISMUTH SUBNITRATE TO OMEPRAZOLE PLUS AMOXICILLIN IMPROVES ERADICATION OF HELICOBACTER-PYLORI

      Alimentary pharmacology & therapeutics
    43. PORRO GB; LAZZARONI M; PETRILLO M; ARDIZZONE S; MANZIONNA G; CARUSO I; MONTRONE F
      PEPTIC-ULCER THERAPY WITH CIMETIDINE VERSUS TRIPOTASSIUM DICITRATO BISMUTHATE IN RHEUMATOID-ARTHRITIS PATIENTS UNDERGOING CHRONIC NSAID TREATMENT

      Alimentary pharmacology & therapeutics
    44. OKUMURA T; SHOJI E; TAKAHASHI N; WAKEBE H; IMAGAWA K; KIKUCHI M; KOHGO Y
      DELAYED GASTRIC-EMPTYING BY HELICOBACTER-PYLORI LIPOPOLYSACCHARIDE INCONSCIOUS RATS

      Digestive diseases and sciences
    45. Sandha, GS; LeBlanc, R; Van Zanten, SJOV; Sitland, TD; Agocs, L; Burford, N; Best, L; Mahoney, D; Hoffman, P; Leddin, DJ
      Chemical structure of bismuth compounds determines their gastric ulcer healing efficacy and anti-Helicobacter pylori activity

      DIGESTIVE DISEASES AND SCIENCES
    46. Marzio, L; Falcucci, M; Grossi, L; Ciccaglione, FA; Malatesta, MG; Castellano, A; Ballone, E
      Proximal and distal gastric distension in normal subjects and H-pylori-positive and -negative dyspeptic patients and correlation with symptoms

      DIGESTIVE DISEASES AND SCIENCES
    47. ODERDA G
      MANAGEMENT OF HELICOBACTER-PYLORI INFECTION IN CHILDREN

      Gut
    48. LANGTRY HD; WILDE MI
      OMEPRAZOLE - A REVIEW OF ITS USE IN HELICOBACTER-PYLORI INFECTION, GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC-ULCERS INDUCED BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      Drugs
    49. VAKIL N; ASHORN M
      COST-EFFECTIVENESS OF NONINVASIVE TESTING AND TREATMENT STRATEGIES FOR HELICOBACTER-PYLORI INFECTION IN CHILDREN WITH DYSPEPSIA

      The American journal of gastroenterology
    50. GISBERT JP; BOIXEDA D; DEARGILA CM
      CURRENT ROLE OF CLARITHROMYCIN IN THE ERA DICATION OF HELICOBACTER-PYLORI

      Revista espanola de enfermedades digestivas
    51. BAFFONE W; BELBUSTI F; BARBIERI E; PIANETTI A; BRUSCOLINI F; FABI MT; SALVAGGIO L; ALBANO A
      COMPARISON OF COLLOIDAL BISMUTH SUBCITRATE AND METRONIDAZOLE, BOTH INCOMBINATION WITH AN H-2 ANTAGONIST AS THERAPY FOR HELICOBACTER-PYLORI

      Journal of chemotherapy
    52. ODERDA G
      CURE OF HELICOBACTER-PYLORI IN CHILDREN

      Helicobacter
    53. LEUNG VKS; VANZANTEN SJOV
      CLINICAL PERSPECTIVE OF HELICOBACTER-PYLORI INFECTION

      Bailliere's clinical infectious diseases
    54. WACK RF; EATON KA; KRAMER LW
      TREATMENT OF GASTRITIS IN CHEETAHS (ACINONYX-JUBATUS)

      Journal of zoo and wildlife medicine
    55. GISBERT JP; BOIXEDA D; DEARGILA CM; BERMEJO F; REDONDO C; DERAFAEL L
      EROSIVE DUODENITIS - PREVALENCE OF HELICOBACTER-PYLORI INFECTION AND RESPONSE TO ERADICATION THERAPY WITH OMEPRAZOLE PLUS 2 ANTIBIOTICS

      European journal of gastroenterology & hepatology
    56. MIEHLKE S; GRAHAM DY
      ANTIMICROBIAL THERAPY OF PEPTIC-ULCERS

      International journal of antimicrobial agents
    57. BLECKER U; GOLD BD
      TREATMENT OF HELICOBACTER-PYLORI INFECTION - A REVIEW

      The Pediatric infectious disease journal
    58. NEBIKI H; ARAKAWA T; HIGUCHI K; KOBAYASHI K
      QUALITY OF ULCER HEALING INFLUENCES THE RELAPSE OF GASTRIC-ULCERS IN HUMANS

      Journal of gastroenterology and hepatology
    59. KALACH N; BENHAMOU PH; RAYMOND J; BARBET P; BRIET F; BERGERET M; FLOURIE B; SENOUCI L; DUPONT C
      HELICOBACTER-PYLORI GASTRIC INFECTIONS IN CHILDREN

      La Presse medicale
    60. ODERDA G; PONZETTO A; BOERO M; BELLIS D; FORNI M; VAIRA D; ANSALDI N
      FAMILY TREATMENT OF SYMPTOMATIC CHILDREN WITH HELICOBACTER-PYLORI INFECTION

      The Italian Journal of Gastroenterology
    61. BARDHAN KD; SINGH S; MORRIS P; THOMPSON M; HINCHLIFFE RFC; CARY BA; WALL RM; BLAKEMORE CB
      MAINTENANCE THERAPY WITH COLLOIDAL BISMUTH SUBCITRATE REDUCES DUODENAL-ULCER RELAPSE

      The Italian Journal of Gastroenterology
    62. ALAMRI SM; ALRASHED RS; HABBAL TM; ALHUMAYED SM; MAYET IY
      EFFICACY OF METRONIDAZOLE-BASED TRIPLE THERAPY ON ERADICATING HELICOBACTER-PYLORI POSITIVE PEPTIC-ULCERS IN MAINLY SAUDI PATIENTS

      Saudi medical journal
    63. PENSTON JG; MCCOLL KEL
      ERADICATION OF HELICOBACTER-PYLORI - AN OBJECTIVE ASSESSMENT OF CURRENT THERAPIES

      British journal of clinical pharmacology
    64. SAMDAL F; GRONG K; SKOLLEBORG KC; GRONBECH JE
      ACUTE EROSIONS OF THE GASTRIC-MUCOSA IN BURNED RATS - EFFECT OF SUCRALFATE

      Scandinavian journal of plastic and reconstructive surgery and hand surgery
    65. MIYAJI H; AZUMA T; ITO S; SUTO H; ITO Y; YAMAZAKI Y; SATO F; HIRAI M; KURIYAMA M; KATO T; KOHLI Y
      SUSCEPTIBILITY OF HELICOBACTER-PYLORI ISOLATES TO METRONIDAZOLE, CLARITHROMYCIN AND AMOXICILLIN IN-VITRO AND IN CLINICAL TREATMENT IN JAPAN

      Alimentary pharmacology & therapeutics
    66. TANAKA S; GUTH PH; CARRYL OR; KAUNITZ JD
      CYTOPROTECTIVE EFFECT OF BISMUTH SUBSALICYLATE IN INDOMETHACIN-TREATED RATS IS ASSOCIATED WITH ENHANCED MUCUS BISMUTH CONCENTRATION

      Alimentary pharmacology & therapeutics
    67. DEGROOT GH; DEBOTH PSM
      CISAPRIDE IN FUNCTIONAL DYSPEPSIA IN GENERAL-PRACTICE - A PLACEBO-CONTROLLED, RANDOMIZED, DOUBLE-BLIND-STUDY

      Alimentary pharmacology & therapeutics
    68. UNGE P
      ASSESSMENT AND SIGNIFICANCE OF HELICOBACTER-PYLORI INFECTION

      Alimentary pharmacology & therapeutics
    69. LAMBERT JR; MIDOLO P
      THE ACTIONS OF BISMUTH IN THE TREATMENT OF HELICOBACTER-PYLORI INFECTION

      Alimentary pharmacology & therapeutics
    70. LI HY; KEOHANE BM; SUN HZ; SADLER PJ
      DETERMINATION OF BISMUTH IN SERUM AND URINE BY DIRECT-INJECTION NEBULIZATION INDUCTIVELY-COUPLED PLASMA-MASS SPECTROMETRY

      Journal of analytical atomic spectrometry
    71. BAGCHI D; CARRYL OR; TRAN MX; BAGCHI M; VUCHETICH PJ; KROHN RL; RAY SD; MITRA S; STOHS SJ
      PROTECTION AGAINST CHEMICALLY-INDUCED OXIDATIVE GASTROINTESTINAL TISSUE-INJURY IN RATS BY BISMUTH SALTS

      Digestive diseases and sciences
    72. RAO N; BROWN PW; YERINO P; CHANG J; HWANG KK
      COMPARATIVE ABSORPTION OF BISMUTH IN SPRAGUE-DAWLEY RATS FOLLOWING ORAL-ADMINISTRATION OF PREPARATIONS CONTAINING BISMUTH SUCROSE OCTASULFATE, BISMUTH SUBSALICYLATE, AND BISMUTH SUBCITRATE

      Biopharmaceutics & drug disposition
    73. MATSUMOTO S; WASHIZUKA Y; MATSUMOTO Y; TAWARA S; IKEDA F; YOKOTA Y; KARITA M
      APPEARANCE OF A METRONIDAZOLE-RESISTANT HELICOBACTER-PYLORI STRAIN INAN INFECTED-ICR-MOUSE MODEL AND DIFFERENCE IN ERADICATION OF METRONIDAZOLE-RESISTANT AND METRONIDAZOLE-SENSITIVE STRAINS

      Antimicrobial agents and chemotherapy
    74. GILVARRY J; BUCKLEY MJM; BEATTIE S; HAMILTON H; OMORAIN CA
      ERADICATION OF HELICOBACTER-PYLORI AFFECTS SYMPTOMS IN NONULCER DYSPEPSIA

      Scandinavian journal of gastroenterology
    75. KATO S; TAKEYAMA J; EBINA K; NAGANUMA H
      OMEPRAZOLE-BASED DUAL AND TRIPLE REGIMENS FOR HELICOBACTER-PYLORI ERADICATION IN CHILDREN

      Pediatrics
    76. GISBERT JP; BOIXEDA D; DEARGILA CM
      INFECTION BY HELICOBACTER-PYLORI - WHERE IS THE LIMIT

      Medicina Clinica
    77. GISBERT JP; MUR M; BOIXEDA D; CENA G; DEARGILA CM; BALERIOLA IA; ABRAIRA V; PLAZA AG
      ONE-WEEK THERAPY WITH OMEPRAZOLE, CLARITH ROMYCIN AND AMOXICILLIN - HIGH EFFICACY IN ERADICATING HELICOBACTER-PYLORI AND HEALING DUODENAL-ULCER

      Medicina Clinica
    78. AGOCS L; BRIAND GG; BURFORD N; CAMERON TS; KWIATKOWSKI W; ROBERTSON KN
      THE STRUCTURALLY FLEXIBLE BICYCLIC BIS(2-HYDROXYETHANETHIOLATO)BISMUTH(III) COMPLEX - A MODEL FOR ASYMMETRIC MONOANIONIC CHELATION OF BISMUTH(III)

      Inorganic chemistry
    79. TALLEY NJ; HUNT RH
      WHAT ROLE DOES HELICOBACTER-PYLORI PLAY IN DYSPEPSIA AND NONULCER DYSPEPSIA - ARGUMENTS FOR AND AGAINST HELICOBACTER-PYLORI BEING ASSOCIATED WITH DYSPEPTIC SYMPTOMS

      Gastroenterology
    80. UNGE P
      WHAT OTHER REGIMENS ARE UNDER INVESTIGATION TO TREAT HELICOBACTER-PYLORI INFECTION

      Gastroenterology
    81. SUN HZ; LI HY; SADLER PJ
      THE BIOLOGICAL AND MEDICINAL CHEMISTRY OF BISMUTH

      Chemische Berichte
    82. ASATO E; KAMAMUTA K; AKAMINE Y; FUKAMI T; NUKADA R; MIKURIYA M; DEGUCHI S; YOKOTA Y
      BISMUTH(III) COMPLEXES OF 2-MERCAPTOETHANOL - PREPARATION, STRUCTURALAND SPECTROSCOPIC CHARACTERIZATION, ANTIBACTERICIDAL ACTIVITY TOWARD HELICOBACTER-PYLORI, AND INHIBITORY EFFECT TOWARD H-PYLORY-PRODUCED UREASE

      Bulletin of the Chemical Society of Japan
    83. TAYLOR JL; ZAGARI M; MURPHY K; FRESTON JW
      PHARMACOECONOMIC COMPARISON OF TREATMENTS FOR THE ERADICATION OF HELICOBACTER-PYLORI

      Archives of internal medicine
    84. BAYERDORFFER E; MIEHLKE S; LEHN N; MANNES GA; HOCHTER W; WEINGART J; KLANN H; SOMMER A; HELDWEIN W; HATZ R; SIMON T; BOLLE KH; BASTLEIN E; MEINING A; RUCKDESCHEL G; STOLTE M
      CURE OF GASTRIC-ULCER DISEASE AFTER CURE OF HELICOBACTER-PYLORI INFECTION - GERMAN GASTRIC-ULCER STUDY

      European journal of gastroenterology & hepatology
    85. ALARCON T; DOMINGO D; SANCHEZ I; DEROJAS FD; LOPEZBREA M
      IN-VITRO ACTIVITY OF OMEPRAZOLE IN COMBINATION WITH SEVERAL ANTIMICROBIAL AGENTS AGAINST CLINICAL ISOLATES OF HELICOBACTER-PYLORI

      European journal of clinical microbiology & infectious diseases
    86. NILSSON JR
      EFFECTS OF A BISMUTH SALT ON CELL-PROLIFERATION, ENDOCYTOSIS, AND FINE-STRUCTURE OF TETRAHYMENA

      European journal of protistology
    87. AKPOLAT I; KAHRAMAN H; ARIK N; AKPOLAT T; KANDEMIR B; CENGIZ K
      ACUTE-RENAL-FAILURE DUE TO OVERDOSE OF COLLOIDAL BISMUTH

      Nephrology, dialysis, transplantation
    88. DELTENRE M; DEKOSTER E; CAUCHETEUR B; OTERO J; JONAS C
      THE ERADICATION OF HELICOBACTER-PYLORI IN 1995 - A CRITICAL-REVIEW OFAVAILABLE TREATMENTS

      Gastroenterologie clinique et biologique
    89. VARANNES SDB; SCARPIGNATO C
      RELATIONSHIPS BETWEEN HELICOBACTER-PYLORI -ASSOCIATED GASTRITIS AND DYSPEPTIC SYMPTOMS

      Gastroenterologie clinique et biologique
    90. BOUCHE O
      SHOULD HELICOBACTER-PYLORI BE ERADICATED IN A PATIENT WITH CHRONIC GASTRITIS

      Gastroenterologie clinique et biologique
    91. CUCCHIARA S; SALVIA G; AZZEQEH N; DARMIENTO F; DEPETRA MR; RAPAGIOLO S; CAMPANOZZI A; EMILIANO M
      HELICOBACTER-PYLORI GASTRITIS AND NONULCER DYSPEPSIA IN CHILDHOOD - EFFICACY OF ONE-WEEK TRIPLE ANTIMICROBIAL THERAPY IN ERADICATING THE ORGANISM

      The Italian Journal of Gastroenterology
    92. KOCH KM; DAVIS IM; GOODING AE; YIN Y
      PHARMACOKINETICS OF BISMUTH AND RANITIDINE FOLLOWING SINGLE DOSES OF RANITIDINE BISMUTH CITRATE

      British journal of clinical pharmacology
    93. KOCH KM; KERR BM; GOODING AE; DAVIS IM
      PHARMACOKINETICS OF BISMUTH AND RANITIDINE FOLLOWING MULTIPLE DOSES OF RANITIDINE BISMUTH CITRATE

      British journal of clinical pharmacology
    94. BARRIE PJ; DJURAN MI; MAZID MA; MCPARTLIN M; SADLER PJ; SCOWEN IJ; SUN HZ
      SOLID-STATE C-13 NUCLEAR-MAGNETIC-RESONANCE INVESTIGATIONS OF BISMUTHCITRATE COMPLEXES AND CRYSTAL-STRUCTURE OF NA-2[BI-2(CIT)(2)]CENTER-DOT-7H(2)O

      Journal of the Chemical Society. Dalton transactions
    95. LAHEIJ RJF; JANSEN JBMJ; VANDELISDONK EH; VERBEEK ALM
      REVIEW ARTICLE - SYMPTOM IMPROVEMENT THROUGH ERADICATION OF HELICOBACTER-PYLORI IN PATIENTS WITH NONULCER DYSPEPSIA

      Alimentary pharmacology & therapeutics
    96. CIOCIOLA AA; WEBB DD; HEATH A; WALSH JH
      EFFECTS OF RANITIDINE BISMUTH CITRATE ON GASTRIC-ACID SECRETION AND GASTRIN-RELEASE IN SUBJECTS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION

      Alimentary pharmacology & therapeutics
    97. TILLMAN LA; DRAKE FM; DIXON JS; WOOD JR
      REVIEW ARTICLE - SAFETY OF BISMUTH IN THE TREATMENT OF GASTROINTESTINAL-DISEASES

      Alimentary pharmacology & therapeutics
    98. PENSTON JG
      REVIEW ARTICLE - CLINICAL ASPECTS OF HELICOBACTER-PYLORI ERADICATION THERAPY IN PEPTIC-ULCER DISEASE

      Alimentary pharmacology & therapeutics
    99. LAZZARONI M; BARGIGGIA S; SANGALETTI O; MACONI G; BOLDORINI M; PORRO GB
      ERADICATION OF HELICOBACTER-PYLORI AND LONG-TERM OUTCOME OF FUNCTIONAL DYSPEPSIA - A CLINICAL ENDOSCOPIC STUDY

      Digestive diseases and sciences
    100. DIMARIO F; BATTAGLIA G; LEANDRO G; GRASSO G; VIANELLO F; VIGNERI S
      SHORT-TERM TREATMENT OF GASTRIC-ULCER - A META-ANALYTICAL EVALUATION OF BLIND TRIALS

      Digestive diseases and sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 23:18:43